Jardine Matheson offers a discounted, cash-generative Asia-Pacific portfolio with an improving capital-allocation model, healthcare growth and an attractive probability-weighted five-year value outcome.
Overview
Jardine Matheson is a diversified Asia-Pacific holding company, established in 1832, whose principal earnings come from Astra, Hongkong Land, DFI Retail, Jardine Pacific, Jardine Cycle & Carriage and Mandarin Oriental. Indonesia contributes 47% of underlying net profit, Hong Kong and Macau 27%, other Southeast Asia 10%, Vietnam 6%, mainland China 5% and the rest of the world 5%. **The central investment story is a transition from a complex owner-operator conglomerate to an active investment holding company.** Management recycled US$4.8 billion in FY2025 and US$1.5 billion in H1 2026, acquired Australia’s I-MED for US$2.4 billion, launched Hongkong Land’s S$8.2 billion SCPREF and privatized Mandarin Oriental. H1 2026 revenue fell 7% to US$15,924 million, but adjusted underlying profit rose 9% to US$735 million, EPS rose 8% to US$2.50 and parent free cash flow rose 21% to US$709 million. FY2025 underlying EPS was US$5.72, with the stock at US$58.20 implying 10.17x P/E and 0.61x P/B versus a 0.9x peer P/B average. **Near-term catalysts are the US$500 million buyback, at least US$2.47 of 2026 dividends, I-MED integration and narrowing of the 25%–35% conglomerate discount.**